Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Family and Preventative Medicine, University of California, San Diego, CA, USA.
Ann Pharmacother. 2011 Mar;45(3):e19. doi: 10.1345/aph.1P669. Epub 2011 Feb 22.
To report a case of drug-induced fever associated with azathioprine treatment in a patient with sarcoidosis.
A 52-year-old man with pulmonary sarcoidosis presented to the emergency department with a 1-day history of fever (temperature 39.9 °C), chills, nausea, and vomiting. One week earlier, azathioprine 50 mg/day had been started for worsening dyspnea. The patient was admitted and evaluated for acute infectious processes. All of his home medications (hydroxychloroquine, prednisone, fluticasone/salmeterol, lovastatin, pantoprazole, zolpidem, ibandronate, albuterol), except prednisone, were held. Results of chest X-ray, viral cultures, and urine and blood cultures revealed no source of infection. The patient's temperature returned to normal within 30 hours after discontinuation of azathioprine; rechallenge was not performed.
Fever as an adverse drug reaction is often unrecognized, particularly in medically complex patients. Azathioprine has been reported to cause drug fever in patients with inflammatory bowel disease and in those with rheumatoid arthritis; to our knowledge, there have been no previous reports documenting azathioprine-induced fever in patients with sarcoidosis. The chronological course of febrile response and defervescence is highly suggestive of drug-induced fever.
The rapid resolution of fever after discontinuation of azathioprine suggests that it was the likely source of fever in this patient. If azathioprine is increasingly prescribed in patients with sarcoidosis, fever as an adverse reaction may become more common.
报告 1 例与柳氮磺胺吡啶治疗相关的药物性发热的病例。
1 例 52 岁男性,患有肺结节病,因发热(体温 39.9°C)、寒战、恶心和呕吐 1 天而就诊于急诊科。1 周前,开始给予柳氮磺胺吡啶 50mg/天治疗,以改善呼吸困难。患者入院并接受急性感染过程的评估。除泼尼松外,所有家庭用药(羟氯喹、泼尼松、氟替卡松/沙美特罗、洛伐他汀、泮托拉唑、唑吡坦、伊班膦酸钠、沙丁胺醇)均已停用。胸部 X 线、病毒培养、尿液和血液培养结果均未发现感染源。在停用柳氮磺胺吡啶后 30 小时内,患者体温恢复正常;未进行再激发试验。
药物不良反应引起的发热常常未被识别,尤其是在患有多种疾病的复杂患者中。柳氮磺胺吡啶已被报道可引起炎症性肠病和类风湿关节炎患者的药物性发热;据我们所知,尚无先前的报告记录柳氮磺胺吡啶引起的结节病患者发热。发热反应和退热的时间顺序高度提示药物性发热。
在停用柳氮磺胺吡啶后,发热迅速消退,提示它可能是该患者发热的原因。如果柳氮磺胺吡啶在结节病患者中越来越多地被使用,作为不良反应的发热可能会变得更加常见。